Jonathan H. LeBowitz
Keine laufenden Positionen mehr
Profil
Dr. Jonathan H.
LeBowitz is Chief Scientific Officer & EVP at ZyStor Therapeutics, Inc. and an Advisor at Venture Investors LLC.
Prior to Venture Investors LLC, Dr. LeBowitz was an Associate Professor of Biochemistry at Purdue University.
Dr. LeBowitz received several PhDs from Harvard University, the Massachusetts Institute of Technology and Johns Hopkins University.
Ehemalige bekannte Positionen von Jonathan H. LeBowitz
| Unternehmen | Position | Ende |
|---|---|---|
| Purdue University | Corporate Officer/Principal | - |
ZyStor Therapeutics, Inc.
 ZyStor Therapeutics, Inc. Medical SpecialtiesHealth Technology ZyStor Therapeutics, Inc. develops innovative therapeutics. It offers enzyme replacement therapies for the treatment of lysosomal storage diseases. The company was founded by Brian L. Clevinger, James S. Manuso and Allan R. Goldberg and is headquartered in Milwaukee, WI. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Jonathan H. LeBowitz
| Harvard University | Doctorate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
| The Johns Hopkins University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
ZyStor Therapeutics, Inc.
ZyStor Therapeutics, Inc. Medical SpecialtiesHealth Technology ZyStor Therapeutics, Inc. develops innovative therapeutics. It offers enzyme replacement therapies for the treatment of lysosomal storage diseases. The company was founded by Brian L. Clevinger, James S. Manuso and Allan R. Goldberg and is headquartered in Milwaukee, WI. | Health Technology |
